US Stock MarketDetailed Quotes

XENE Xenon Pharmaceuticals

Watchlist
  • 41.150
  • +1.350+3.39%
Close Nov 22 16:00 ET
  • 43.000
  • +1.850+4.50%
Post 20:01 ET
3.14BMarket Cap-14644P/E (TTM)

About Xenon Pharmaceuticals Company

Xenon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It develops therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions. The company's products include XEN496, XEN1101, XEN901 and XEN007. Xenon Pharmaceuticals was founded by Simon Neil Pimstone, Johannes J. P. Kastelein and Michael R. Hayden on November 5, 1996 and is headquartered in Burnaby, Canada.

Company Profile

SymbolXENE
Company NameXenon Pharmaceuticals
Listing DateNov 5, 2014
Issue Price9.00
Founded1996
CEOMr. Ian C. Mortimer
MarketNASDAQ
Employees259
Fiscal Year Ends12-31
Address3650 Gilmore Way,Suite 200
CityBurnaby
ProvinceBritish Columbia
CountryCanada
Zip CodeV5G 4W8
Phone1-604-484-3300
Websitehttp://www.xenon-pharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Ian C. Mortimer
  • Director, Chief Executive Officer and President
  • 9.77M
  • Andrea DiFabio
  • Chief Legal Officer and Corporate Secretary
  • --
  • Sherry Aulin
  • Chief Financial Officer and Principal Accounting Officer
  • 3.52M
  • Christopher John Kenney
  • Chief Medical Officer
  • 3.58M
  • Dr. Christopher E. Von Seggern, PhD
  • Chief Commercial Officer
  • 2.76M
  • James R. Empfield
  • Executive Vice President, Drug Discovery
  • --
  • Dr. Robin Sherrington, PhD
  • Executive Vice President, Strategy and Innovation
  • 2.37M
  • Steven Gannon
  • Independent Director
  • 561.42K
  • Dr. Gillian M. Cannon, PhD
  • Independent Director
  • 770.91K
  • Dawn A. Svoronos
  • Lead Independent Director
  • 588.37K
  • Justin David Gover
  • Independent Director
  • 770.91K
  • Dr. Elizabeth A. Garofalo, M.D.
  • Independent Director
  • 548.57K
  • Patrick C. Machado, J.D.
  • Independent Director
  • 559.58K
  • Gary Patou, M.D.
  • Independent Director
  • 560.09K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data